Neoplasia (chapter 7) Flashcards
ERBB1 (EGFR)
adenocarcinoma of the lung
ERBB2 (HER)
breast carcinoma
RET
multiple endocrine neoplasia 2A and 2B
PDGFRB
gliomas
KIT
gastrointestinal stromal tumors
ALK
adenocarcinoma of the lung
KRAS
colon, lung, pancreatic cancers
NRAS
melanomas, hematologic malignancies
GNAS
pituitary adenoma, other endocrine tumors
(bcr) ABL
chronic myeloid leukemia
acute lymphoblastic leukemia
BRAF
melanomas
JAK2
myeloproliferative disorders
C-MYC
Burkitt lymphoma
N-MYC
neuroblastoma
L-MYC
small-cell (oat cell) carcinoma of lung
CCND1 (cyclin D)
mantle cell lymphoma
(9;22)(q34;q11)/BCR-ABL
chronic myelogenous leukemia
(8;14)(q24;q32)/C-MYC
Burkitt lymphoma
(11;22)(q24;q12)/FLI1/EWSR1
Ewing sarcoma
CDK4/D cyclins (gene function)
phosphorylate RB, allow cell to progress through G1 restriction point
INK4/ARF family (CDKN2A-C) (gene function)
p16/INK4a - binds cyclinD/CDK4, promotes inhibitory effects of RB
p14/ARF - increases p53 levels
RB (gene function)
tumor suppressor; prevents G1/S transition
p53 (gene function)
tumor suppressor; causes cell cycle arrest and apoptosis
required for G1/S checkpoint, main component of G2/M checkpoint
NF1
neurofibromatosis type 1 (neurofibromas, malignant peripheral nerve sheath tumors)
NF2
neurofibromatosis type 2 (acoustic schwannoma, meningioma)
PTCH
Gorlin syndrome (basal cell carcinoma)
PTEN
Cowden syndrome
RB
retinoblastoma, osteosarcoma
VHL
von Hippel Lindau syndrome (renal cell carcinoma)
E-cadherin
familial gastric cancer
TP53
Li-Fraumeni syndrome
BRCA1, BRCA2
familial breast and ovarian carcinoma
WT1
familial Wilms tumor
MEN1
multiple endocrine neoplasia 1 (pituitary, parathyroid, and pancreatic endocrine tumors)
Cushing syndrome (paraneoplastic)
small-cell carcinoma of lung; ACTH
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) (paraneoplastic)
small-cell carcinoma of lung; ADH